Arqit Announces A Partnership With Dell Technologies To Bring Quantum-Safe Solutions To Its Customers

Arqit Quantum Inc. (NASDAQ:ARQQ, ARQQW)))) ("Arqit"), a leader in quantum-safe encryption announces that it has signed with Dell Technologies ("Dell") a "Dell OEM Engineered Solutions Pilot

Arqit Quantum Inc. (NASDAQ:ARQQ, ARQQW))))) (“Arqit”), a leader in quantum-safe encryption announces that it has signed with Dell Technologies (“Dell”) a “Dell OEM Engineered Solutions Pilot Agreement”. Dell agrees to preload Arqit’s QuantumCloud™ software on selected Dell hardware devices, enabling Dell sales teams to sell the combined hardware and software as a single SKU to address existing and new customer needs.
 

The initial target market is the US Federal Government, including the Department of Defense (DoD), the Federal Civilian Agencies and the Intelligence Community. Dell sales teams will be able to offer Arqit QuantumCloud™ software and Arqit sales teams will be able to offer Dell hardware and services in their sales portfolios. 

Arqit’s QuantumCloud™ is a unique symmetric key agreement software which solves the problems of Public Key Infrastructure (PKI) and the quantum computing threat. QuantumCloud™ is the only product in the world with an independently assured security proof demonstrating that its cloud fulfilled symmetric encryption keys are zero trust and quantum-safe.

The combined solution architecture for the DoD enables Dell’s industry leading standards of excellence and quality with quantum-safe encryption capability. QuantumCloud™ is capable of protecting today against “Harvest Now, Decrypt Later” quantum computing attacks and greatly improves the security of a variety of applications, something unachievable with other post quantum cryptographic methods. With the ability to digitally rotate symmetric keys in real time and dynamically manage security groups the solution offers significant mission advantage across today’s growing threat surface.

Arqit Founder, Chairman and CEO David Williams, said: “We are honored to work with Dell, the leader in providing intrinsically secure infrastructure and devices, comprehensive threat detection and response, data protection and cyber recovery to government customers. America’s service men and women need to be assured of the benefits of stronger, simpler encryption to protect them against threats now and in future. By partnering with the very best innovator in the industry we have a great opportunity to do that in a comprehensive way.”

Total
0
Shares
Related Posts
Read More

Why Processa Pharmaceuticals Stock Is Soaring

Processa Pharmaceuticals shares are soaring Thursday after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine. Processa said the data obtained from the Phase 1b trial has been used to select two dosage regimens for the Phase 2 trial which will be in advanced or metastatic breast cancer given the FDA's agreement that the Phase 1b data can be used to support the design of the Phase 2 trial in breast cancer.

PCSA